慢性淋巴细胞白血病高危亚型在诊断前16年即可检出
该研究对124例慢性淋巴细胞白血病(CLL)患者和118名匹配对照诊断前最多22年的血样进行B细胞受体(BcR)免疫球蛋白重链(IGH)基因库测序,发现多数患者诊断前已出现BcR IGH基因库显著偏斜,且14例患者诊断前16年即检出与不良预后相关的重大刻板亚群优势克隆型,提示CLL临床前期可能比既往认为的更长。
要点
- CLL诊断前多年即可检出BcR IGH基因库显著偏斜,早于淋巴细胞增多出现
- 14例患者诊断前16年即检出与不良预后相关的刻板亚群优势克隆型
- 纵向样本显示BcR IGH基因库偏斜随时间显著增加或维持高水平
核心结论
- CLL的临床前期可能比既往认为的更长,即使对不良预后病例也是如此。
研究设计与样本
- 对124例CLL患者和118名匹配对照诊断前最多22年的血样进行BcR IGH基因库测序。
主要发现
- 多数患者诊断前即出现BcR IGH基因库显著偏斜,早于淋巴细胞增多且与IGHV体细胞超突变状态无关。
- 14例CLL患者诊断前16年即检出与不良预后相关的重大刻板亚群优势克隆型。
- 22例纵向样本中BcR IGH基因库偏斜随时间显著增加或维持高水平。
- 16例有诊断时样本的患者中14例诊断前样本已存在CLL克隆型。
临床怎么用
- 对高危人群可考虑早期检测BcR IGH基因库偏斜及刻板亚群克隆型以识别CLL高危个体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic lymphocytic leukemia (CLL) is preceded by monoclonal B-cell lymphocytosis (MBL), a CLL precursor state with a prevalence of up to 12% in aged individuals; however, the duration of MBL and the mechanisms of its evolution to CLL remain largely unknown. In this study, we sequenced the B-cell receptor (BcR) immunoglobulin heavy chain (IGH) gene repertoire of 124 patients with CLL and 118 matched controls in blood samples taken up to 22 years prior to diagnosis. Significant skewing in the BcR IGH gene repertoire was detected in the majority of patients, even before the occurrence of lymphocytosis and irrespective of the clonotypic IGH variable gene somatic hypermutation status. Furthermore, we identified dominant clonotypes belonging to major stereotyped subsets associated with poor prognosis up to 16 years before diagnosis in 14 patients with CLL. In 22 patients with longitudinal samples, the skewing of the BcR IGH gene repertoire increased significantly over time to diagnosis or remained stable at high levels. For 14 of 16 patients with available samples at diagnosis, the CLL clonotype was already present in the prediagnostic samples. Overall, our data indicate that the preclinical phase of CLL could be longer than previously thought, even in adverse-prognostic cases.
引用
- Kolijn PM, Hosnijeh FS, Späth F, et al. High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis. Blood. 2022. PMID: 34662377. doi:10.1182/blood.2021012890
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。